Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 22.32% is 41% above its 5-year average of 15.80%, around the middle of its 5-year range (4.31%–31.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.18% below its 12-month average of 23.79%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 22.32%.
DEBT TO ASSETS RATIO
22.32%
DEBT TO ASSETS RATIO AVG TTM
23.79%
DEBT TO ASSETS RATIO AVG 3Y
19.87%
DEBT TO ASSETS RATIO AVG 5Y
15.80%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-6.18%
CURRENT VS 3Y AVG
+12.34%
CURRENT VS 5Y AVG
+41.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 662 covered companies
CURRENT VS SECTOR MEDIAN
+22216.55%
vs the sector median at left
Precision BioSciences, Inc.
Market Cap
$174.49M
Debt to Assets Ratio
22.32%
TTM Avg
23.79%
3Y Avg
19.87%
5Y Avg
15.80%
Market Cap
$175.80M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.60M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.21M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.02M
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.86M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $174.49M | 22.32% | 23.79% | 19.87% | 15.80% |
| Cue Biopharma, Inc. (CUE)vs › | $175.80M | 0.29% | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $172.78M | 0.22% | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.52M | 0.13% | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.60M | 0.05% | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | 0.16% | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $180.02M | 0.26% | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $166.26M | 0.12% | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $182.86M | 0.00% | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | 0.20% | N/A | N/A | N/A |
Debt/Assets
22.3%
Debt/Equity
0.62
Current Ratio
12.82
Interest Coverage
-36.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 22.32% |
| 2026-03-31 | 19.78% |
| 2025-12-31 | 18.66% |
| 2025-09-30 | 31.15% |
| 2025-06-30 | 27.03% |
| 2025-03-31 | 23.91% |
| 2024-12-31 | 22.03% |
| 2024-09-30 | 19.78% |
| 2024-06-30 | 18.58% |
| 2024-03-31 | 16.81% |
| 2023-12-31 | 19.57% |
| 2023-09-30 | 14.52% |
| 2023-06-30 | 15.40% |
| 2023-03-31 | 13.01% |
| 2022-12-31 | 10.48% |
| 2022-09-30 | 10.11% |
| 2022-06-30 | 9.38% |
| 2022-03-31 | 4.79% |
| 2021-12-31 | 4.31% |
| 2021-09-30 | 5.08% |
| 2021-06-30 | 5.22% |
| 2021-03-31 | 3.83% |
| 2020-12-31 | 7.01% |
| 2020-09-30 | 6.50% |
| 2020-06-30 | 5.93% |
| 2020-03-31 | 5.23% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 31.44% |
| 2018-12-31 | 0.00% |
